ESSA Pharma Inc. (NASDAQ:EPIX – Get Free Report) (TSE:EPI) passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.93 and traded as low as $5.00. ESSA Pharma shares last traded at $5.37, with a volume of 89,307 shares changing hands.
ESSA Pharma Price Performance
The firm’s 50 day moving average is $5.96 and its two-hundred day moving average is $5.81. The firm has a market capitalization of $246.21 million, a P/E ratio of -8.81 and a beta of 1.83.
ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) last released its earnings results on Monday, August 5th. The company reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.10. Analysts anticipate that ESSA Pharma Inc. will post -0.71 EPS for the current fiscal year.
Institutional Investors Weigh In On ESSA Pharma
ESSA Pharma Company Profile
ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.
Read More
- Five stocks we like better than ESSA Pharma
- What is the Nasdaq? Complete Overview with History
- Texas Roadhouse Stock Steering for New Highs This Year
- The How And Why of Investing in Oil Stocks
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Retail Stocks Investing, Explained
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.